Dr. Reddy's Laboratories Limited
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	3/31/2021	3/31/2022	3/31/2024	3/31/2026	3/31/2027	3/31/2028
Revenue % change YoY	₹189.72B N/A	₹214.39B 13.00%	₹279.16B 30.21%	Avg: ₹322.36B Low: ₹268.63B High: ₹375.26B avg. 15.47%	Avg: ₹322.55B Low: ₹270.73B High: ₹366.18B avg. 0.05%	Avg: ₹446.72B Low: ₹374.94B High: ₹507.13B avg. 38.49%
Net Income % change YoY	₹17.23B N/A	₹23.56B 36.72%	₹55.68B 136.26%	Avg: ₹56.60B Low: ₹40.69B High: ₹72.00B avg. 1.64%	Avg: ₹48.71B Low: ₹38.54B High: ₹57.28B avg. -13.93%	Avg: ₹53.88B Low: ₹42.62B High: ₹63.35B avg. 10.60%
EBITDA % change YoY	₹45.70B N/A	₹52.64B 15.17%	₹88.27B 67.68%	Avg: ₹88.52B Low: ₹73.76B High: ₹103.04B avg. 0.28%	Avg: ₹88.57B Low: ₹74.34B High: ₹100.55B avg. 0.05%	Avg: ₹122.67B Low: ₹102.96B High: ₹139.26B avg. 38.49%
EPS % change YoY	$103.94 N/A	$142.08 36.69%	$66.93 -52.89%	Avg: $339.52 Low: $244.09 High: $431.93 avg. 407.27%	Avg: $292.22 Low: $231.18 High: $343.6 avg. -13.93%	Avg: $323.22 Low: $255.71 High: $380.05 avg. 10.60%
Operating Expenses % change YoY	₹70.11B N/A	₹76.80B 9.53%	₹95.87B 24.83%	Avg: ₹101.32B Low: ₹84.43B High: ₹117.95B avg. 5.68%	Avg: ₹101.38B Low: ₹85.09B High: ₹115.09B avg. 0.05%	Avg: ₹140.41B Low: ₹117.85B High: ₹159.40B avg. 38.49%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of -0.55% in 2026-2028.

We have gathered data from 31 analysts. Their low estimate is 40.69B, average is 56.60B and high is 72.00B.

Wall Street analysts forecast annual average revenue growth of 18.00% in 2026-2028.

We have gathered data from 31 analysts. Their low revenue estimate is ₹268.63B, average is ₹322.36B and high is ₹375.26B.

Wall Street analysts forecast annual average earnings growth of 134.64% in 2026-2028.

We have gathered data from 31 analysts. Their low earnings per share estimate is $244.09, average is $339.52 and high is ₹431.93.